%0 Generic
%B Lancet Diabetes Endocrinol
%D 2020
%P 27-35
%R 10.1016/s2213-8587(19)30384-5
%T Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
%V 8